Creo Medical Group plc launches robotic-guided lung ablation procedures in the UK

Phase I/II clinical trial of Ariceum Therapeutics' 225Ac-SSO110 gets US FDA approval

HUTCHMED receives full NMPA approval for ORPATHYS in China for MET exon 14 skipping NSCLC

bioAffinity Technologies declares successful beta launch of CyPath Lung in Texas

Nuformix submits Orphan Drug Application for NXP002 in IPF

hVIVO completes pilot study for hMPV challenge model

Daiichi Sankyo and AstraZeneca's datopotamab deruxtecan receives US Priority Review for EGFR-mutated NSCLC

RYBREVANT plus LAZCLUZE shows significant improvement in overall survival for lung cancer, says J&J

BerGenBio initiates lung cancer trial with bemcentinib and pacritinib

Nuvation Bio secures NMPA approval for taletrectinib in China

GSK's Nucala approved in China for chronic rhinosinusitis with nasal polyps

Hanx Biopharmaceuticals reports first patient dosed in Phase 1 clinical trial of HX044

HUTCHMED announces NDA acceptance in China with priority review for ORPATHYS and TAGRISSO combination in lung cancer

Innovent and Roche agree exclusive global licence for novel DLL3 ADC

Inogen secures FDA clearance for SIMEOX 200 Airway Clearance Device